feed,title,long_url,short_url
Benzinga,"ALX Oncology Has 'Elevated Valuation' - Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancer",https://benzinga.com/analyst-ratings/analyst-color/24/03/37566272/alx-oncology-has-elevated-valuation-analyst-downgrades-stock-highlights-need-for-de,https://da.gd/vWGw1j
